Form 144/A ARROWHEAD PHARMACEUTICAL Filed by: Hamilton James C
Tweet
Share
E-mailATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU approves Arrowhead's plozasiran for rare triglyceride disorder
- University of Phoenix study in The Geography Teacher examines how awe and the "overview effect" may shape geography learning
- SystImmune Announces First Approval of Iza-bren for the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma in China
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
